Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 26;13(11):1536.
doi: 10.3390/jpm13111536.

Improving Strength and Fatigue Resistance in Post-Polio Syndrome Individuals with REAC Neurobiological Treatments

Monalisa Pereira Motta  1 , Acary Souza Bulle Oliveira  1 , Jeyce Adrielly André Nogueira  1 , Alcione Aparecida Vieira de Souza Moscardi  2 , Claudete Munhoz Teixeira  1 , Vanessa Manchim Favaro  1 , Amanda Orasmo Simcsik  1 , Salete Conde  1 , Maria Clara Patrizi  1 , Chiara Rinaldi  3   4   5   6 , Vania Fontani  4   5   6 , Salvatore Rinaldi  4   5   6
Affiliations

Improving Strength and Fatigue Resistance in Post-Polio Syndrome Individuals with REAC Neurobiological Treatments

Monalisa Pereira Motta et al. J Pers Med. .

Abstract

Post-Polio Syndrome (PPS) is a chronic condition characterized by the emergence of new symptoms and functional decline in individuals who previously had polio. Despite advances in medical understanding, management of PPS remains challenging. This study aimed to evaluate the use of neurobiological modulation treatments using Radio Electric Asymmetric Conveyer (REAC) technology on fatigue and muscle strength. An open-label study was conducted with 17 patients submitted to four neuromodulation protocols: Neuro Postural Optimization (NPO), Neuro Psycho Physical Optimization (NPPO), Neuro Psycho Physical Optimization-Cervico Brachial (NPPO-CB), and Neuromuscular Optimization (NMO). The Time Up and Go (TUG) test, Handgrip Strength Test, and Revised Piper Fatigue Scale (RPFS) were used to assess participants' fatigue and muscle strength, being applied at the beginning and end of each protocol. The results obtained from the improvement in strength, physical endurance, and particularly the RPFS behavioral dimension, affective dimension, and psychological sensory dimension, through the utilization of REAC neurobiological modulation treatments, highlight this correlation. These results suggest that these treatments could be considered as a potential therapeutic approach for PPS.

Keywords: handgrip strength; manual muscle testing; neurobiological modulation; piper fatigue scale; post-polio syndrome; radio electric asymmetric conveyer; time up and go test.

PubMed Disclaimer

Conflict of interest statement

S.R. and V.F. are the authors of the REAC technology patent. C.R. is the daughter of S.R. and V.F. The other authors declare no conflict of interest.

Figures

Figure 1
Figure 1
T0: pre-interventional assessments; T1: Administration of REAC NPO; T2: Post-REAC NPO/pre-NPPOs assessments; T3: post-REAC NPPOs/pre-NMO assessments; T4: post-REAC NMO assessments.
Figure 2
Figure 2
The figure shows the mean Time up and Go test time scores at T0, T2, T3, and T4.
Figure 3
Figure 3
The figure shows the average scores of hand grip test at moments T0, T2, T3, and T4.
Figure 4
Figure 4
The figure shows the averages of the Revised Piper Fatigue Scale general fatigue scores at moments T0, T2, T3, and T4.
Figure 5
Figure 5
Means of Revised Piper Fatigue Scale dimensions at moments T0, T2, T3, and T4.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Sáinz M., Pelayo R., Laxe S., Castaño B., Capdevilla E., Portell E. Describing post-polio syndrome. [(accessed on 1 July 2023)];Neurologia. 2022 37:346–354. doi: 10.1016/j.nrl.2019.03.011. Available online: https://www.ncbi.nlm.nih.gov/pubmed/35672121. - DOI - PubMed
    1. Farbu E., Gilhus N.E., Barnes M.P., Borg K., De Visser M., Driessen A., Howard R., Nollet F., Opara J., Stalberg E. EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force. [(accessed on 1 July 2023)];Eur. J. Neurol. 2006 13:795–801. doi: 10.1111/j.1468-1331.2006.01385.x. Available online: https://www.ncbi.nlm.nih.gov/pubmed/16879288. - DOI - PubMed
    1. Gawne A.C., Halstead L.S. Post-polio syndrome: Historical perspective, epidemiology and clinical presentation. [(accessed on 1 July 2023)];NeuroRehabilitation. 1997 8:73–81. doi: 10.3233/NRE-1997-8202. Available online: https://www.ncbi.nlm.nih.gov/pubmed/24525978. - DOI - PubMed
    1. Ragonese P., Fierro B., Salemi G., Randisi G., Buffa D., D’Amelio M., Aloisio A., Savettieri G. Prevalence and risk factors of post-polio syndrome in a cohort of polio survivors. [(accessed on 1 July 2023)];J. Neurol. Sci. 2005 236:31–35. doi: 10.1016/j.jns.2005.04.012. Available online: https://www.ncbi.nlm.nih.gov/pubmed/16014307. - DOI - PubMed
    1. Ramlow J., Alexander M., LaPorte R., Kaufmann C., Kuller L. Epidemiology of the post-polio syndrome. [(accessed on 1 July 2023)];Am. J. Epidemiology. 1992 136:769–786. doi: 10.1093/aje/136.7.769. Available online: https://www.ncbi.nlm.nih.gov/pubmed/1442743. - DOI - PubMed

LinkOut - more resources